News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Foster Wayne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Foster Wayne (EVP, Chief Accounting Officer) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $7.14, valued at
$856.8k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2020 |
4
| Foster Wayne (See Remarks) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $24, valued at
$960k
|
|
| 01/25/2019 |
4
| Foster Wayne (Vice President of Finance) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 30,750 options to buy
@ $3.51, valued at
$107.9k
|
|
| 02/06/2018 |
4
| Foster Wayne (Vice President of Finance) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 20,250 options to buy
@ $14.23, valued at
$288.2k
|
|
| 02/01/2018 |
4
| Foster Wayne (Vice President of Finance) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 889 options to buy
@ $1.62, valued at
$1.4k
Exercised 8,055 options to buy
@ $1.53, valued at
$12.3k
Exercised 3,262 options to buy
@ $4.1, valued at
$13.4k
Exercised 2,499 options to buy
@ $6.98, valued at
$17.4k
|
|
|
|